HomeNewsTechnologyKerala tech firm's Zoom-alternative Vconsol wins government's innovation challenge

Kerala tech firm's Zoom-alternative Vconsol wins government's innovation challenge

Kerala-based Techgentsia Software Technologies will be provided financial support of Rs 1 crore with an additional Rs 10 lakhs towards O&M (operation and maintenance) for the next three years.

August 21, 2020 / 21:50 IST
Story continues below Advertisement

Vconsol, a product of Kerala-based Techgentsia Software Technologies, won the Centre's "Innovation Challenge for Development of Video Conferencing Solution" on August 20. Union Minister Ravi Shankar Prasad announced the winner, who was awarded the prize money of Rs 1 crore with an additional Rs 10 lakhs towards O&M (operation and maintenance) for the next three years.

Launched in April, the challenge was aimed at encouraging Indian companies to bring out secure alternatives of video conferencing apps, including Zoom, without compromising on user security and privacy.

Story continues below Advertisement

The Kerala-based company was founded in 2009 and specialises in internet communication and collaboration. Its business includes hardware- and software-based videoconferencing, having conducted research and development in the space for more than a decade.

Techgentsia Software’s clients include small and medium firms and multinationals from the US and Europe. The company’s videoconferencing solution for the contest is called Vconsol.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show